Alvotech USA, INC.
Biopharmaceutical co. focused on the development & manufacturing of biosimilar medicines
Based in VA
AI Overview
With $120K in lobbying spend across 6 quarterly filings, Alvotech USA, INC is an active lobbying client. They deploy 19 individual lobbyists Their lobbying covers 2 issue areas. Active from 2021 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $120K |
| 2022 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Alvotech USA, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Copyright/Patent, Health Issues
Issues involving patents and prescription drugs, issues involving biosimilar drugs.
Monitoring efforts involving patents and prescription drugs.
Monitoring efforts involving patents and prescription drugs.
Promoting access to biosimilars.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.